Multi-component discriminant analysis delivered five biomarkers (IL-6, CCL11/eotaxin, CCL5/RANTES, collagen Iα, sIL-2R) for the diagnosis of CRMO. The gene discussed is CCL5; the disease is chronic recurrent multifocal osteomyelitis.